"Glaucoma, Neovascular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.
| Descriptor ID |
D015355
|
| MeSH Number(s) |
C11.525.381.348
|
| Concept/Terms |
Glaucoma, Neovascular- Glaucoma, Neovascular
- Glaucomas, Neovascular
- Neovascular Glaucoma
- Neovascular Glaucomas
|
Below are MeSH descriptors whose meaning is more general than "Glaucoma, Neovascular".
Below are MeSH descriptors whose meaning is more specific than "Glaucoma, Neovascular".
This graph shows the total number of publications written about "Glaucoma, Neovascular" by people in this website by year, and whether "Glaucoma, Neovascular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glaucoma, Neovascular" by people in Profiles.
-
Shalaby WS, Ganjei AY, Wogu B, Myers JS, Moster MR, Razeghinejad R, Lee D, Kolomeyer NN, Eid TE, Katz LJ, Shukla AG. Outcomes of Ahmed glaucoma valve and transscleral cyclophotocoagulation in neovascular glaucoma. Indian J Ophthalmol. 2022 Apr; 70(4):1253-1259.
-
Shalaby WS, Myers JS, Razeghinejad R, Katz LJ, Pro M, Dale E, Fudemberg SJ, Mantravadi AV, Shukla AG. Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma. Ophthalmol Glaucoma. 2021 Mar-Apr; 4(2):182-192.
-
Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I. Topical bevacizumab for neovascular glaucoma: a pilot study. Pharmacology. 2014; 93(3-4):108-12.
-
Kaliki S, Eagle RC, Grossniklaus HE, Campbell RJ, Shields CL, Shields JA. Inadvertent implantation of aqueous tube shunts in glaucomatous eyes with unrecognized intraocular neoplasms: report of 5 cases. JAMA Ophthalmol. 2013 Jul; 131(7):925-8.
-
Mashayekhi A, Tuncer S, Shields CL, Shields JA. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma. Eur J Ophthalmol. 2013 May-Jun; 23(3):399-409.
-
Shields CL, Hogarty MD, Kligman BE, Christian C, Ehya H, Shields JA. Langerhans cell histiocytosis of the uvea with neovascular glaucoma: diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy. J AAPOS. 2010 Dec; 14(6):534-7.
-
Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 2008 May; 28(5):696-702.
-
Bianciotto C, Shields CL, Kang B, Shields JA. Treatment of iris melanoma and secondary neovascular glaucoma using bevacizumab and plaque radiotherapy. Arch Ophthalmol. 2008 Apr; 126(4):578-9.
-
Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther. 2007 Oct; 23(5):487-91.
-
Shields CL, Zahler J, Falk N, Furuta M, Eagle RC, Espinosa LE, Fischer PR, Shields JA. Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child. Arch Ophthalmol. 2007 Jun; 125(6):840-2.